Research Publication

Book chapters

Original articles

  1. Akiko Tanaka, Kentaro Takayama, Tomoyuki Furubayashi, Kenji Mori, Yuki Takemura, Mayumi Amano, Chiaki Maeda, Daisuke Inoue, Shunsuke Kimura, Akiko Kiriyama, Hidemasa Katsumi, Mikiya Miyazato, Kenji Kangawa, Toshiyasu Sakane, Yoshio Hayashi, Akira Yamamoto. Transnasal delivery of the peptide agonist specific to neuromedin-U receptor 2 to the brain for the treatment of obesity. Mol. Pharm., 17, 32-39, (2020)
  2. Hiroki Ukai, Arisa Kawagoe, Erika Sato, Masaki Morishita, Hidemasa Katsumi, Akira Yamamoto. Propylene glycol caprylate as a novel potential absorption enhancer for improving the intestinal absorption of insulin: Efficacy, safety, and absorption-enhancing mechanisms. J. Pharm. Sci., 2020,109, 1483-1492, (2020)
  3. Tomoyuki Furubayashi, Daisuke Inoue, Noriko Nishiyama, Akiko Tanaka, Reiko Yutani, Shunsuke Kimura, Hidemasa Katsumi, Akira Yamamoto, Toshiyasu Sakane. Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats. Pharmaceutics, 12, 79, (2020)
  4. Iichiro Kawahara, Satoyo Nishikawa, Akira Yamamoto, Yusuke Kono, Takuya Fujita. Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice. Pharmacol. Res. Perspect., 8, e00544, (2020)
  5. Iichiro Kawahara, Satoyo Nishikawa, Akira Yamamoto, Yusuke Kono, and Takuya Fujita. The impact of breast cancer resistance protein (BCRP/ABCG2) on drug transport across Caco-2 cell monolayers. Drug Metab. Dispos., 48, 491-498, (2020)
  6. Kentaro Takayama, Kenji Mori, Akiko Tanaka, Yu Sasaki, Yuko Sohma, Akihiro Taguchi, Atsuhiko Taniguchi, Toshiyasu Sakane, Akira Yamamoto, Mikiya Miyazato, Naoto Minamino, Kenji Kangawa , Yoshio Hayashi. A chemically stable peptide agonist to neuromedin U receptor type 2. Bioorg. Med. Chem., 28, 115454, (2020)
  7. Hiroki Ukai, Kazuki Iwasa, Takamasa Deguchi, Masaki Morishita, Hidemasa Katsumi, Akira Yamamoto. Enhanced intestinal absorption of insulin by Capryol 90, a novel absorption enhancer in rats: Implications in oral insulin delivery. Pharmaceutics, 12, 462, (2020)
  8. Shugo Yamashita, Hidemasa Katsumi, Erika Shimizu, Yuto Nakao, Ayane Yoshioka, Minako Fukui, Hiroyuki Kimura, Toshiyasu Sakanea, Akira Yamamoto. Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis. Eur. J. Pharm. Biopharm., 157, 85-96, (2020)
  9. Hiroki Ukai, Ayako Imanishi, Ayaka Kaneda, Erika Kimura, Miku Koyama, Masaki Morishita, Hidemasa Katsumi, Akira Yamamoto. Absorption-enhancing mechanisms of Capryol 90, a novel absorption enhancer, for improving the intestinal absorption of poorly absorbed drugs: Contributions to trans- or para-cellular pathways. Pharm. Res., 37, 248, (2020)
  10. Wen Liu 1, Yuki Takahashi, Masaki Morishita, Makiya Nishikawa, Yoshinobu Takakura. Development of CD40L-modified tumor small extracellular vesicles for effective induction of antitumor immune response. Nanomedicine (Lond), 15, 1641-1652, (2020)

Review articles

Proceedings

Presentation

Lectures

Others